ScholarIQanswers from OpenAlex

Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice

PaperCitations, authors & open-access status

Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice have?

ScholarIQcitation count

Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice has 148 citations in the OpenAlex counts ScholarIQ stores.

When was Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice published?

ScholarIQyear

Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice has 2013 year in the ScholarIQ index.

What is the open-access status of Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice?

ScholarIQoa status

Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice has hybrid oa status in the ScholarIQ index.

What is the DOI of Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice?

ScholarIQdoi

The DOI for Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice is on the source record.

What is the PMID of Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice?

ScholarIQpmid

The PMID for Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice is on the source record.

What is the OpenAlex record for Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice?

ScholarIQopenalex

The OpenAlex for Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial